63 hasil untuk "Ugo Testa"
Menampilkan 1–20 · 0,35 detik · RSS
-
Artikel Jurnal Teks lengkap
Complex Karyotype and TP53 Alterations in AML and MDS
Background/Objectives: A complex karyotype (CK) in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDSs) is defined as the presence of three or more unrelated chromosomal abnormalities in the absence of defining core-binding factor translocations. Losses/Deletions on chromosomes 5, 7…
-
Artikel Jurnal Teks lengkap
Blastic Plasmacytoid Dendritic Cell Neoplasm in the Era of Targeted Therapies
Blastic plasmocytoid dendritic cell neoplasm (BPDCN) is a rare myeloid malignancy, characterized by the involvement of multiple organs, including the skin, bone marrow and blood, lymph nodes and the central nervous system. According to tumor location, the disease is classified as skin-only…
-
Artikel Jurnal
ROLE OF STEM CELL FACTOR IN THE REACTIVATION OF HUMAN FETAL HEMOGLOBIN
<p>In humans the switch from fetal to adult hemoglobin (HbF→ HbA) takes place in the perinatal and postnatal period, determining the progressive replacement of HbF with HbA synthesis ( i.e., the relative HbF content in red blood cells decreases from 80-90% to <1%). In spite of more…
-
Artikel Jurnal
ROLE OF STEM CELL FACTOR IN THE REACTIVATION OF HUMAN FETAL HEMOGLOBIN
In humans the switch from fetal to adult hemoglobin (HbF→ HbA) takes place in the perinatal and postnatal period, determining the progressive replacement of HbF with HbA synthesis ( i.e., the relative HbF content in red blood cells decreases from 80-90% to
-
Artikel Jurnal
Deregulation of apoptosis in acute myeloid leukemia
Apoptosis, or programmed cell death, is central to the development and homeostasis of the hematopoietic system. Dysregulation of apoptosis plays an important role in the development of a variety of human pathologies, including cancer, autoimmune diseases and neurodegenerative disorders. Studies…
-
Artikel Jurnal Teks lengkap
Melanoma: Genetic Abnormalities, Tumor Progression, Clonal Evolution and Tumor Initiating Cells
Melanoma is an aggressive neoplasia issued from the malignant transformation of melanocytes, the pigment-generating cells of the skin. It is responsible for about 75% of deaths due to skin cancers. Melanoma is a phenotypically and molecularly heterogeneous disease: cutaneous, uveal, acral, and…
-
Artikel Jurnal Teks lengkap
Cellular and Molecular Mechanisms Underlying Prostate Cancer Development: Therapeutic Implications
Prostate cancer is the most frequent nonskin cancer and second most common cause of cancer-related deaths in man. Prostate cancer is a clinically heterogeneous disease with many patients exhibiting an aggressive disease with progression, metastasis, and other patients showing an indolent disease…
-
Artikel Jurnal Teks lengkap
Breast Cancer: A Molecularly Heterogenous Disease Needing Subtype-Specific Treatments
Breast cancer is the most commonly occurring cancer in women. There were over two-million new cases in world in 2018. It is the second leading cause of death from cancer in western countries. At the molecular level, breast cancer is a heterogeneous disease, which is characterized by high genomic…
-
Artikel Jurnal Teks lengkap
Esophageal Cancer: Genomic and Molecular Characterization, Stem Cell Compartment and Clonal Evolution
Esophageal cancer (EC) is the eighth most common cancer and is the sixth leading cause of death worldwide. The incidence of histologic subtypes of EC, esophageal adenocarcinoma (EAC) and esophageal squamous carcinoma (ESCC), display considerable geographic variation. EAC arises from metaplastic…
-
Artikel Jurnal Teks lengkap
Precision Medicine for Older AML Patients
The development of molecular profiling approaches for AML patients such as whole genome sequencing, whole exome sequencing and transcriptomic sequencing have greatly contributed to better understanding of leukemia development, progression and treatment responsiveness/resistance. These studies have…
-
Artikel Jurnal Teks lengkap
Molecular Complexity of MDS and AML with Aberrations of Chromosome 7
Complete or partial deletions of chromosome 7 (-7/del7q) represent the most frequent chromosomal abnormalities observed in myeloid neoplasms (MNs) and are associated with a poor prognosis. -7/del7q is observed in 10–15% of adult patients with myelodysplasia (MDS) or with acute myeloid leukemia…
-
Artikel Jurnal
New promising developments for potential therapeutic applications of high-dose ascorbate as an anticancer drug
Vitamin C (ascorbate) is an essential dietary requirement, with fundamental redox, antioxidant functions at physiologic concentrations. Vitamin C is a cofactor for Fe2+ and 2- oxoglutarate-dependent dioxygenases, englobing large families of enzymes, including also epigenetic regulators of DNA and…
-
Artikel Jurnal Teks lengkap
Genetic, Phenotypic, and Clinical Heterogeneity of NPM1-Mutant Acute Myeloid Leukemias
The current classification of acute myeloid leukemia (AML) relies largely on genomic alterations. AML with mutated nucleophosmin 1 (NPM1-mut) is the largest of the genetically defined groups, involving about 30% of adult AMLs and is currently recognized as a distinct entity in the actual AML…
-
Artikel Jurnal Teks lengkap
Genetic Alterations in Renal Cancers: Identification of The Mechanisms Underlying Cancer Initiation and Progression and of Therapeutic Targets
Renal cell cancer (RCC) involves three most recurrent sporadic types: clear-cell RCC (70–75%, CCRCC), papillary RCCC (10–15%, PRCC), and chromophobe RCC (5%, CHRCC). Hereditary cases account for about 5% of all cases of RCC and are caused by germline pathogenic variants. Herein, we review how a…
-
Artikel Jurnal Teks lengkap
Genetic Abnormalities, Clonal Evolution, and Cancer Stem Cells of Brain Tumors
Brain tumors are highly heterogeneous and have been classified by the World Health Organization in various histological and molecular subtypes. Gliomas have been classified as ranging from low-grade astrocytomas and oligodendrogliomas to high-grade astrocytomas or glioblastomas. These tumors are…
-
Artikel Jurnal Teks lengkap
Pancreatic Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells
Pancreatic Ductal Adenocarcinoma (PDAC) is the fourth most common cause of cancer-related death and is the most lethal of common malignancies with a five-year survival rate of <10%. PDAC arises from different types of non-invasive precursor lesions: intraductal papillary mucinous neoplasms…
-
Artikel Jurnal Teks lengkap
Colorectal Cancer: Genetic Abnormalities, Tumor Progression, Tumor Heterogeneity, Clonal Evolution and Tumor-Initiating Cells
Colon cancer is the third most common cancer worldwide. Most colorectal cancer occurrences are sporadic, not related to genetic predisposition or family history; however, 20–30% of patients with colorectal cancer have a family history of colorectal cancer and 5% of these tumors arise in the setting…
-
Artikel Jurnal Teks lengkap
Molecular Abnormalities and Associated Clinical Features in Polycythemia Vera
Background/Objectives: Myeloproliferative neoplasms are a group of clonal myeloid malignancies that affect bone marrow and include polycythemia vera (PV), essential thrombocythemia (ET) and primary myelofibrosis (PMF). PV is caused in most patients by the JAK2-V617F mutation and is characterized at…
-
Artikel Jurnal
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA
TP53-mutated myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) form a distinct and heterogeneous group of myeloid malignancies associated with poor outcomes. Studies carried out in the last years have in part elucidated the complex role played by TP53 mutations in the pathogenesis of…
-
Artikel Jurnal Teks lengkap
Clonal Hematopoiesis, a Risk Condition for Developing Myeloid Neoplasia
Clonal hematopoiesis (CH) is an age-related process in which hematopoietic stem/progenitor cells increase their fitness due to the acquisition of mutations that lead to a proliferative advantage and to clonal expansion. Its frequency increases with age, and it mostly affects people older than 70…